TCR2 Therapeutics Inc. EPS - Earnings per Share 2019-2023 | TCRR
TCR2 Therapeutics Inc. eps - earnings per share from 2019 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| TCR2 Therapeutics Inc. Annual EPS |
| 2022 |
$-3.93 |
| 2021 |
$-2.63 |
| 2020 |
$-2.40 |
| 2019 |
$-4.62 |
| 2018 |
$-98.53 |
| 2017 |
$-39.94 |
| 2016 |
$-38.64 |
| TCR2 Therapeutics Inc. Quarterly EPS |
| 2023-03-31 |
$-1.03 |
| 2022-12-31 |
$-1.56 |
| 2022-09-30 |
$-0.79 |
| 2022-06-30 |
$-0.82 |
| 2022-03-31 |
$-0.76 |
| 2021-12-31 |
$-0.72 |
| 2021-09-30 |
$-0.69 |
| 2021-06-30 |
$-0.64 |
| 2021-03-31 |
$-0.58 |
| 2020-12-31 |
$-0.52 |
| 2020-09-30 |
$-0.56 |
| 2020-06-30 |
$-0.67 |
| 2020-03-31 |
$-0.65 |
| 2019-12-31 |
$1.27 |
| 2019-09-30 |
$-0.58 |
| 2019-06-30 |
$-0.46 |
| 2019-03-31 |
$-4.85 |
| 2018-12-31 |
$-14.41 |
| 2018-09-30 |
$-27.25 |
| 2018-06-30 |
$-27.97 |
| 2018-03-31 |
$-28.90 |
